Guillem Pintos-Morell

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Drug design, development and therapy

Genes

International journal of molecular sciences

Journal of clinical medicine

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Universitat Autònoma de Barcelona Facultat de Medicina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Jan 01 2014

Spain

Member :: CIBERER-GCV08, Neuromuscular & Neuropediatrics group

CATALAN INSTITUTE OF HEALTH (ICS). VALL D'HEBRON BARCELONA HOSPITAL CAMPUS Dec 01 2017 - Sep 21 2020

Spain

CLINICAL DIRECTOR :: UNIT of RARE DISEASES

Universitat Autònoma de Barcelona Jan 01 1991 - Aug 31 2020

Spain

Associate Professor Vall d'Hebron Teaching Unit :: Pediatrics

Hospital Universitari Germans Trias i Pujol Jan 01 2016 - Oct 31 2017

Spain

Head of Department :: Pediatrics

Education History

Universitat Autònoma de Barcelona Facultat de Medicina

Spain

PHD :: Pediatria

Publications

Raquel Barbero, María Garriga-García, Ana Moreno-Blanco, Esther Palacios, Pedro Ruiz-Sala, Saioa Vicente-Santamaría, Sinziana Stanescu, Amaya Belanger-Quintana, Guillem Pintos-Morell, Beatriz Arconada, Rosa Del Campo, José Avendaño-Ortiz
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected Siblings. International journal of molecular sciences 25 (16) (2024)
Raquel Barbero, María Garriga-García, Ana Moreno-Blanco, Esther Palacios, Pedro Ruiz-Sala, Saioa Vicente-Santamaría, Sinziana Stanescu, Amaya Belanger-Quintana, Guillem Pintos-Morell, Beatriz Arconada, Rosa Del Campo, José Avendaño-Ortiz
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected Siblings. International journal of molecular sciences 25 (16) (2024)
Clara Carnicer-Cáceres, Jose Antonio Arranz-Amo, Cristina Cea-Arestin, Maria Camprodon Gómez, David Moreno-Martinez, Sara Lucas-Del-Pozo, Marc Moltó-Abad, Ariadna Tigri-Santiña, Irene Agraz-Pamplona, Jose F Rodriguez-Palomares, Jorge Hernández-Vara, Mar Armengol-Bellapart, Mireia Del-Toro-Riera, Guillem Pintos-Morell
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up. Journal of clinical medicine 10 (8) (2021)
Rossella Parini, Guillem Pintos-Morell, Julia B Hennermann, Ting-Rong Hsu, Nesrin Karabul, Vasiliki Kalampoki, Andrey Gurevich, Uma Ramaswami, null null
Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age. Drug design, development and therapy 14 (2020)
Ibane Abasolo, Joaquin Seras-Franzoso, Marc Moltó-Abad, Zamira Vanessa Díaz-Riascos, José Luis Corchero, Guillem Pintos-Morell, Simó Schwartz
Nanotechnology-based approaches for treating lysosomal storage disorders, a focus on Fabry disease. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 13 (3) (2020)
Alfonsina Ballester-Lopez, Ian Linares-Pardo, Emma Koehorst, Judit Núñez-Manchón, Guillem Pintos-Morell, Jaume Coll-Cantí, Miriam Almendrote, Giuseppe Lucente, Andrea Arbex, Jonathan Javier Magaña, Nadia M Murillo-Melo, Alejandro Lucia, Darren G Monckton, Sarah A Cumming, Alba Ramos-Fransi, Alicia Martínez-Piñeiro, Gisela Nogales-Gadea
The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1. Genes 11 (7) (2020)
Alfonsina Ballester-Lopez, Emma Koehorst, Ian Linares-Pardo, Judit Núñez-Manchón, Miriam Almendrote, Giuseppe Lucente, Andrea Arbex, Carles Puente, Alejandro Lucia, Darren G Monckton, Sarah A Cumming, Guillem Pintos-Morell, Jaume Coll-Cantí, Alba Ramos-Fransi, Alicia Martínez-Piñeiro, Gisela Nogales-Gadea
Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1. Genes 11 (11) (2020)
Uma Ramaswami, Michael Beck, Derralynn Hughes, Christoph Kampmann, Jaco Botha, Guillem Pintos-Morell, Michael L West, Dau-Ming Niu, Kathleen M Nicholls, Roberto Giugliani, null null
Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis. Drug design, development and therapy 13 (2019)
Alfonsina Ballester-Lopez, Emma Koehorst, Miriam Almendrote, Alicia Martínez-Piñeiro, Giuseppe Lucente, Ian Linares-Pardo, Judit Núñez-Manchón, Nicolau Guanyabens, Antoni Cano, Alejandro Lucia, Gayle Overend, Sarah A Cumming, Darren G Monckton, Teresa Casadevall, Irina Isern, Josep Sánchez-Ojanguren, Albert Planas, Agustín Rodriguez-Palmero, Laura Monlleó-Neila, Guillem Pintos-Morell, Alba Ramos-Fransi, Jaume Coll-Cantí, Gisela Nogales-Gadea
A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype. Human mutation 41 (2) (2019)
Karin Tuschl, Esther Meyer, Leonardo E Valdivia, Ningning Zhao, Chris Dadswell, Alaa Abdul-Sada, Christina Y Hung, Michael A Simpson, W K Chong, Thomas S Jacques, Randy L Woltjer, Simon Eaton, Allison Gregory, Lynn Sanford, Eleanna Kara, Henry Houlden, Stephan M Cuno, Holger Prokisch, Lorella Valletta, Valeria Tiranti, Rasha Younis, Eamonn R Maher, John Spencer, Ania Straatman-Iwanowska, Paul Gissen, Laila A M Selim, Guillem Pintos-Morell, Wifredo Coroleu-Lletget, Shekeeb S Mohammad, Sangeetha Yoganathan, Russell C Dale, Maya Thomas, Jason Rihel, Olaf A Bodamer, Caroline A Enns, Susan J Hayflick, Peter T Clayton, Philippa B Mills, Manju A Kurian, Stephen W Wilson
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nature communications 7 (2016)

Guillem Pintos-Morell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guillem Pintos-Morell